Huawei Cloud Computing Technologies Co., Ltd.

Microport Sinica Co., Ltd.

Xiao Cheng

Guangtai Liang

Lin Li

Fei Chen

Lu Chen

Junfei Li

Zhao Wei

Shanbin Cheng

Zeyu Wang

Tianyong Wu

In a software code change method, an apparatus determines to-be-changed software code and change configuration information according to an instruction of a user. The apparatus selects, from stored changers based on the change configuration information, a plurality of changers to be called to implement changes to the software code, and determines a calling sequence of the plurality of changers and sets attributes of each changer. The apparatus then sequentially calls the plurality of changers according to the calling sequence and based on the attributes of each changer to make changes to the software code.

Software code change method and apparatus

In a code analysis method, a code analysis system obtains information about a service scenario that represents an objective of code analysis. The code analysis system generates a code analysis algorithm for the service scenario based on the information about the service scenario. When code analysis needs to be performed, the code analysis system obtains information about source code and object code that are specified by a user, and analyzes similarity between the source code and the object code according to the code analysis algorithm to obtain an analysis result. The similarity between the source code and the object code is analyzed according to the code analysis algorithm generated based on the information about the service scenario, to obtain the analysis result that meets a requirement of the service scenario.

Code analysis method and system, and computing device

Disclosed is use of amlexanox or a salt thereof or a solvate thereof in preparation of a drug having an inhibitory action on the smooth muscle cells, in particular a drug for preventing and treating vascular restenosis. Further disclosed is a medical device, particularly a drug stent, the surface of which is distributed with amlexanox or the salt thereof or the pharmaceutical composition thereof. Amlexanox has an activity in inhibition of the proliferation of smooth muscle cells, has a low inhibitory property of the endothelial cell growth, is particularly suitable for applying on a medical device to prevent the incidence of vascular restenosis, while not delaying the repair of endothelium.

Use of amlexanox

Growing community of inventors

Shanghai, China

Xiao Cheng